Bartlett & Co. LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,160 filers reported holding NOVARTIS A G in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.

Quarter-by-quarter ownership
Bartlett & Co. LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q4 2023$15,100
-3.1%
151,046
-1.3%
0.24%
-12.5%
Q3 2023$15,589
-0.8%
153,046
-1.7%
0.28%
+2.9%
Q2 2023$15,719
+2.2%
155,768
-7.1%
0.27%
-8.4%
Q1 2023$15,388
-4.6%
167,593
-5.8%
0.30%
-8.6%
Q4 2022$16,137
-99.9%
177,871
-1.9%
0.32%
+9.8%
Q3 2022$13,778,000
-11.5%
181,265
-1.5%
0.30%
-6.0%
Q2 2022$15,563,000
-17.7%
184,113
-14.5%
0.32%
-4.5%
Q1 2022$18,905,000
+0.1%
215,442
-0.3%
0.33%
+3.1%
Q4 2021$18,892,000
+4.6%
215,985
-2.2%
0.32%
-7.2%
Q3 2021$18,067,000
-10.8%
220,923
-0.5%
0.34%
-10.9%
Q2 2021$20,258,000
+3.1%
222,033
-3.4%
0.39%
-2.0%
Q1 2021$19,649,000
-12.1%
229,870
-2.9%
0.40%
-17.2%
Q4 2020$22,352,000
+6.7%
236,702
-1.7%
0.48%
-2.9%
Q3 2020$20,939,000
+2.2%
240,786
+2.6%
0.49%
-8.2%
Q2 2020$20,487,000
+4.6%
234,571
-1.3%
0.54%
-10.4%
Q1 2020$19,595,000
-8.9%
237,663
-4.0%
0.60%
+5.7%
Q3 2019$21,504,000
-8.5%
247,460
-3.8%
0.56%
-35.6%
Q2 2019$23,498,000
-45.5%
257,345
-42.6%
0.88%
-46.8%
Q1 2019$43,088,000
+11.3%
448,179
-0.7%
1.65%
-0.1%
Q4 2018$38,728,000
-1.2%
451,320
-0.8%
1.65%
+12.2%
Q3 2018$39,191,000
+13.7%
454,866
-0.3%
1.47%
+5.0%
Q2 2018$34,459,000
-8.8%
456,175
-2.4%
1.40%
-10.2%
Q1 2018$37,786,000
-4.2%
467,356
-0.5%
1.56%
-0.6%
Q4 2017$39,438,000
-2.9%
469,727
-0.7%
1.57%
-7.8%
Q3 2017$40,614,000
+4.5%
473,081
+1.6%
1.70%
-2.7%
Q2 2017$38,883,000
+12.3%
465,832
-0.1%
1.75%
+11.0%
Q1 2017$34,621,000
+2.3%
466,155
+0.3%
1.58%
-1.4%
Q4 2016$33,839,000
-4.9%
464,568
+3.1%
1.60%
-6.9%
Q3 2016$35,565,000
-3.5%
450,421
+0.8%
1.72%
-5.7%
Q2 2016$36,858,000
+15.3%
446,714
+1.2%
1.82%
+13.5%
Q1 2016$31,978,000
-14.0%
441,444
+2.1%
1.60%
-16.4%
Q4 2015$37,188,000
-6.7%
432,213
-0.3%
1.92%
-12.2%
Q3 2015$39,849,000
-6.8%
433,523
-0.3%
2.18%
+1.9%
Q2 2015$42,752,000
-1.8%
434,737
-1.5%
2.14%
-0.9%
Q1 2015$43,538,000
+4.2%
441,522
-2.1%
2.16%
+7.3%
Q4 2014$41,794,000
-3.9%
451,049
-2.3%
2.02%
-4.0%
Q3 2014$43,478,000
+2.5%
461,896
-1.4%
2.10%
+2.9%
Q2 2014$42,406,000
+3.1%
468,414
-3.1%
2.04%
-0.1%
Q1 2014$41,114,000
+4.9%
483,581
-0.9%
2.04%
+4.3%
Q4 2013$39,205,000
+3.4%
487,746
-1.3%
1.96%
-4.6%
Q3 2013$37,911,000
+7.1%
494,215
-1.3%
2.05%
+5.4%
Q2 2013$35,413,000500,8171.95%
Other shareholders
NOVARTIS A G shareholders Q1 2023
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders